Tenders/task 111 - Lenalidomidum
Open🇵🇱PolandSupplies

task 111 - Lenalidomidum

Auto-translated from Polish
Original title: zadanie 111 - Lenalidomidum
Uniwersytecki Szpital Kliniczny nr 4 w Lublinie
Published: Nov 13, 2026
Updated: Nov 15, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Auto-translated from Polish
This tender from Poland, task number 111, concerns the supply of the drug Lenalidomidum. Lenalidomidum is a medication used in the treatment of certain types of cancer, including multiple myeloma and myelodysplastic syndromes. The contracting authority is seeking a supplier for this vital pharmaceutical. Procurement of pharmaceuticals typically requires bidders to provide evidence of authorization to distribute the drug, adherence to stringent quality standards, and compliance with all relevant Polish and European pharmaceutical regulations. Key requirements often include the ability to supply the drug in specified dosages and quantities, ensure product integrity throughout the supply chain, and meet delivery deadlines. Competitive pricing, product availability, and the validity period of the medication are also crucial evaluation factors. The objective is to guarantee a consistent and reliable supply of Lenalidomidum to patients who require this specific cancer therapy.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on November 13, 2026. Last refreshed 2 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Uniwersytecki Szpital Kliniczny nr 4 w Lublinie

Uniwersytecki Szpital Kliniczny nr 4 w Lublinie has issued 172 procurement notices on BidsFactory, including 8 currently open and 83 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Architecture & Engineering Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: November 18, 2026.

Uniwersytecki Szpital Kliniczny nr 4 w Lublinie: buyer profile, tenders and awards

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Uniwersytecki Szpital Kliniczny nr 4 w Lublinie in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans